PULMATRIX INC (PULM:NASDAQ)
$1.36 0.02 (1.4925%)
Analysed PULMATRIX INC (PULM:NASDAQ) News Sources
Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets
06-08-2025
yahoo.com
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets
16-10-2025
yahoo.com
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
18-12-2025
yahoo.com
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results
26-02-2026
yahoo.com
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
02-03-2026
yahoo.com
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
03-03-2026
yahoo.com
Wave crashes on obesity drug update; Kodiak’s reboot pays dividends
26-03-2026
biopharmadive.com
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
26-03-2026
yahoo.com
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
21-04-2026
yahoo.com
Pulmatrix Announces First Quarter 2026 Financial Results
15-05-2026
yahoo.com
What is the current price of PULMATRIX INC (PULM:NASDAQ)?
The current price of PULMATRIX INC (PULM:NASDAQ) is $1.36.
PULMATRIX INC (PULM:NASDAQ) absolute price change since previous trading day?
The absolute price change of PULMATRIX INC (PULM:NASDAQ) since the previous trading day is $0.02.
PULMATRIX INC (PULM:NASDAQ) percentage price change since previous trading day?
The percentage price change of PULMATRIX INC (PULM:NASDAQ) since the previous trading day is 1.4925%.
What is the most recent average sentiment score for PULMATRIX INC (PULM:NASDAQ)?
The most recent average sentiment score for PULMATRIX INC (PULM:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for PULMATRIX INC (PULM:NASDAQ)?
The most recent sentiment for PULMATRIX INC (PULM:NASDAQ) is .
SEC-8K** Filing Available For PULMATRIX INC (PULM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.